Ibnsina Pharma: EBRD Exits 8.8% Stake Via Egyptian Exchange

Deal News | Feb 06, 2025 | Zawya

Ibnsina Pharma: EBRD Exits 8.8% Stake Via Egyptian Exchange

In a strategic move, the European Bank for Reconstruction and Development (EBRD) has successfully exited its 8.8% stake in Ibnsina Pharma via the Egyptian Exchange (EGX). The EBRD's investment in Egypt's leading pharmaceutical distributor began in 2015 when it acquired a 20% stake to support the company's development by funding infrastructure improvements. The collaboration contributed significantly to Ibnsina's growth, as acknowledged by its CEO, Omar Abdel Gawad. Hassan Massoud of the EBRD commended the successful exit during a turbulent economic environment, emphasizing the EGX's role as a reliable exit venue. The EBRD, a founding financial supporter in Egypt since 2012, has a history of investing in the country's private sector, with over 13.8 billion invested across various industries. Their investment strategy has diversified to include sectors such as renewable energy and healthcare, highlighting their focus on bolstering Egypt's economic development.

Sectors

  • Pharmaceuticals
  • Private Equity
  • Financial Services

Geography

  • Egypt – The transaction took place in Egypt, involving the Egyptian Exchange and a local pharmaceutical firm.

Industry

  • Pharmaceuticals – Ibnsina Pharma is a leading distributor of pharmaceutical products in Egypt, reflecting the industry's focus.
  • Private Equity – The EBRD's investment and exit from Ibnsina Pharma involve private equity activities.
  • Financial Services – The news involves investment activities through the Egyptian Exchange, a financial services platform.

Financials

  • 8.8% – The stake exited by the EBRD in Ibnsina Pharma.
  • 13.8 billion – Total investment by the EBRD in Egypt across 196 projects.

Participants

NameRoleTypeDescription
Ibnsina PharmaTarget CompanyCompanyA leading pharmaceutical distributor in Egypt, founded in 2000.
European Bank for Reconstruction and Development (EBRD)SellerCompanyA major investor supporting the private sector in Egypt since 2012.
Omar Abdel GawadCEOPersonCEO of Ibnsina Pharma.
Hassan MassoudOverseeing EBRD's Private Equity Business - Southern MediterraneanPersonResponsible for private equity activities at the EBRD in the southern Mediterranean.